Pharmaceutical marking approach improves traceability
Engineers at Cambridgeshire-based GB Innomech are helping to develop a new approach to uniquely mark pharmaceutical and related healthcare products, and improve product traceability.

The technique will allow faster identification and resolution of any manufacturing quality problems, but will also prove invaluable as an anti-counterfeit measure because the specific coding and validation systems are almost impossible to copy.
Currently, most components within diagnostic kits, medical devices and other healthcare products and equipment are ’stamped’ with a lot code at the point of manufacture. However, these codes are of limited use for quality improvement unless products are produced in very small batches.
As a result, regulatory bodies across the world are now putting manufacturers under increasing pressure to invest in much more sophisticated traceability systems, while manufacturers are looking for effective ways to prevent the growing problem of counterfeiting of pharmaceuticals and other healthcare products.
The approach being developed by Innomech will enable manufacturers to mark products with a code that is either unique to the item or shared by only a small number of items produced together.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Comment: Engineers must adapt to AI or fall behind
A fascinating piece and nice to see a broad discussion beyond GenAI and the hype bandwagon. AI (all flavours) like many things invented or used by...